"Banish the word 'struggle' from your attitude and your vocabulary. All that we do now must be done in a sacred manner and in celebration. We are the ones we have been waiting for." — Hopi elders
Sponsored by
The Multidisciplinary Association for Psychedelic Studies - MAPS Official Group
All
Topics
Start a discussion on Evolver. Other members will be able to join in.
Events
Announcements
Members
 admin |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
|
 |
|
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
|
 |
 |
 |
|
|
 |
|
 |
 |
 |
 |
 |
|
A non-profit organization supporting psychedelic and marijuana research since 1986.
MAPS is a 501 (c) (3) nonprofit chartered in 1986 as a membership–based research and educational organization. It was founded one year after the federal Drug Enforcement Administration made 3,4-Methylenedioxymethamphetamine (MDMA) a Schedule 1 drug and criminalized its recreational and therapeutic uses. MDMA is a unique medication that we believe has the potential to enhance the psychotherapeutic process and should become a prescription medicine.
We are developing and funding clinical trials with human subjects in accordance with guidelines set forth by the U.S. Food and Drug Administration, the European Medicines Agency and the International Council on Harmonization. Simultaneously, we are training therapists to administer psychedelic drugs in therapeutic settings.
We are a nonprofit pharmaceutical company working to develop generic drugs. We estimate it will take $10 million and 10 years to conduct the research necessary to prove the safety and efficacy of either MDMA or marijuana for just one clinical application to the satisfaction of the FDA and the European Medicines Agency.
We believe psychedelics and marijuana, when used in proper settings, can aid in psychotherapeutic treatment for a variety of psychological issues, including PTSD, end-of-life anxiety, depression, drug addiction, and pain.
We believe psychedelics' and marijuana's benefits and risks to physiology, cognitive function and creativity should be thoroughly researched.
We pursue our mission by helping and/or sponsoring scientific researchers to design, obtain government approval for, fund, conduct and report on psychedelic and marijuana research with human volunteers.
We also pursue our mission by maintaining our website to ensure people have access to factual information about MDMA, psychedelics and marijuana research; We make ourselves available to the media in order to provide a factual and informed perspective on psychedelics and marijuana; We publish books, produce a magazine-style Bulletin, and send out regular e-newsletters about contemporary issues related to psychedelic and marijuana research and therapy; We provide experts to speak at universities, conferences and other events.
